Core-shell upconversion MOFs photosensitive composite material, preparation method and application thereof
A composite material and nanocomposite material technology, applied in the preparation, application of synergistic chemotherapy and near-infrared photodynamic therapy, the field of core-shell up-conversion MOFs photosensitive composite material, can solve the problems such as MOFs photosensitizers that have not been found yet, and achieve excellent resistance. effect of tumor
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] The core-shell up-conversion MOFs photosensitive composite material that the present embodiment provides, it is above-conversion nanoparticle NaYF 4 :Yb,Er@NaYF 4 As the core, the photosensitive Al-MOF is used as the shell, and the shell is loaded with the anticancer drug DOX at the same time MOFs structure nanocomposite, that is, UCNP@MOF-DOX; the nanocomposite emits red light when excited by 980 nm near-infrared light light and green light; the upconversion nanoparticles NaYF 4 :Yb,Er@NaYF 4 In, the dosage of Yb is NaYF 4 15%~25% of molar weight, be 15% in the present embodiment; The consumption of Er is NaYF 4 1% to 3% of the molar weight, the present embodiment is 1%. The MOFs structure is Al-MOF, wherein Al-MOF and NaYF 4 :Yb,Er@NaYF 4 The concentration ratio is 1:2. The anticancer drug DOX is doxorubicin hydrochloride, and its mass proportion is 7.0% to 8.0% of the total mass of the UCNP@MOF-DOX nanocomposite material, which is 7% in this embodiment.
[00...
Embodiment 2
[0056] The core-shell up-conversion MOFs photosensitive composite material, preparation method and application provided in this example are basically the same as those in Example 1, except that:
[0057] In the core-shell up-conversion MOFs photosensitive composite material provided by this embodiment, the up-conversion nanoparticles NaYF 4 :Yb,Er@NaYF 4 In, the dosage of Yb is NaYF 4 20% of the molar weight, the amount of Er is NaYF 4 2% of the molar amount; the anticancer drug DOX is doxorubicin hydrochloride, and its mass ratio is 7.5% of the total mass of the UCNP@MOF-DOX nanocomposite.
[0058] Described step (1) comprises following concrete steps:
[0059] (11) Take 0.78 mmol Y(CH 3 COO) 3 , 0.2 mmol of Yb (CH 3 COO) 3 and 0.02 mmol of Er(CH 3 COO) 3 ) metal-acetate precursor, placed in a 100 mL flask containing a mixed solution of 6 mL OA and 15 mL ODE; heated to 150 °C to form a homogeneous solution, then cooled to below 60 °C; heated to 150 °C C forms the re...
Embodiment 3
[0066] The core-shell up-conversion MOFs photosensitive composite material, preparation method and application provided in this example are basically the same as those in Examples 1 and 2, except that:
[0067] In the core-shell up-conversion MOFs photosensitive composite material provided by this embodiment, the up-conversion nanoparticles NaYF 4 :Yb,Er@NaYF 4 In, the dosage of Yb is NaYF 4 25% of the molar weight, the amount of Er is NaYF 4 3% of the molar amount; the anticancer drug DOX is doxorubicin hydrochloride, and its mass ratio is 8% of the total mass of the UCNP@MOF-DOX nanocomposite.
[0068] The core-shell UCNP@MOF upconversion nanomaterial is the upconversion nanoparticle as the core, and the photosensitive Al-MOF as the shell while loading the anticancer drug DOX in a set ratio.
PUM
Property | Measurement | Unit |
---|---|---|
size | aaaaa | aaaaa |
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com